Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 How is Her-2/neu status established when Her-2/neu and chromosome 17 centromere are both amplified?

× No keyword cloud information.

6 in total

1. Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status.

Authors: Kirsten Vang Nielsen; Bent Ejlertsen; Susanne Møller; Maj-Britt Jensen; Eva Balslev; Sven Müller; Ann Knoop; Henning T Mouridsen
Journal: Mol Oncol Date: 2011-11-26 Impact factor: 6.603

2. Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity.

Authors: Shelly Gunn; I-Tien Yeh; Irina Lytvak; Budi Tirtorahardjo; Natasha Dzidic; Soheila Zadeh; Jaeweon Kim; Chris McCaskill; Lony Lim; Mercedes Gorre; Mansoor Mohammed
Journal: BMC Cancer Date: 2010-07-28 Impact factor: 4.430

3. Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines for HER2 Testing by Fluorescence In Situ Hybridization: Experience of an Academic Consultation Practice.

Authors: Michael F Press; Ivonne Villalobos; Angela Santiago; Roberta Guzman; Monica Cervantes; Armen Gasparyan; Anaamika Campeau; Yanling Ma; Denice D Tsao-Wei; Susan Groshen
Journal: Arch Pathol Lab Med Date: 2016-04-15 Impact factor: 5.534

4. Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines.

Authors: Michael F Press; Jose A Seoane; Christina Curtis; Emmanuel Quinaux; Roberta Guzman; Guido Sauter; Wolfgang Eiermann; John R Mackey; Nicholas Robert; Tadeusz Pienkowski; John Crown; Miguel Martin; Vicente Valero; Valerie Bee; Yanling Ma; Ivonne Villalobos; Dennis J Slamon
Journal: JAMA Oncol Date: 2019-03-01 Impact factor: 31.777

5. HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials.

Authors: Michael F Press; Guido Sauter; Marc Buyse; Hélène Fourmanoir; Emmanuel Quinaux; Denice D Tsao-Wei; Wolfgang Eiermann; Nicholas Robert; Tadeusz Pienkowski; John Crown; Miguel Martin; Vicente Valero; John R Mackey; Valerie Bee; Yanling Ma; Ivonne Villalobos; Anaamika Campeau; Martina Mirlacher; Mary-Ann Lindsay; Dennis J Slamon
Journal: J Clin Oncol Date: 2016-10-10 Impact factor: 44.544

6. Retrospective analysis of the association between human epidermal growth factor receptor 2 amplification and chromosome enumeration probe 17 status in patients with breast cancer.

Authors: Xiaoyu Hu; Yanan Li; Dong Yuan; Ruohan Li; Lingquan Kong; Hongyuan Li; Zhu Yang; Qiubo Yu
Journal: Oncol Lett Date: 2017-09-06 Impact factor: 2.967

6 in total